NanoVibronix (NAOV) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free NAOV Stock Alerts $0.72 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | businesswire.comNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract AwardApril 10, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023April 9, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMarch 28, 2024 | finance.yahoo.comNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldFebruary 23, 2024 | benzinga.comMagnolia Oil & Gas Stock (NYSE:MGY), Quotes and News SummaryFebruary 2, 2024 | uk.finance.yahoo.comNanoVibronix, Inc. (NAOV)January 25, 2024 | marketbeat.comTrading was temporarily halted for "NAOV" at 11:01 AM with a stated reason of "LULD pause."January 7, 2024 | morningstar.comNanoVibronix Inc NAOVDecember 6, 2023 | finance.yahoo.comNanoVibronix Featured in Your Bladder Health MagazineDecember 4, 2023 | finance.yahoo.comNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNovember 28, 2023 | markets.businessinsider.comNanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of MichiganNovember 28, 2023 | finance.yahoo.comNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNovember 7, 2023 | finance.yahoo.comNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1September 27, 2023 | finanznachrichten.deNanoVibronix, Inc.: NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug TariffSeptember 27, 2023 | finance.yahoo.comNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffSeptember 6, 2023 | finance.yahoo.comNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingAugust 31, 2023 | seekingalpha.comAMC, MMLP and ARAV among mid-day moversAugust 30, 2023 | msn.comNanoVibronix to raise $5M through private placementAugust 30, 2023 | finance.yahoo.comWhy Is NanoVibronix Stock Trading Higher Today?August 30, 2023 | finance.yahoo.comNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesAugust 30, 2023 | investorplace.comWhy Is NanoVibronix (NAOV) Up 153% Today?August 30, 2023 | finance.yahoo.comNanoVibronix Cites Positive Results from Independent Testing of UroShieldAugust 29, 2023 | finance.yahoo.comNanoVibronix Responds to CMS’ Determination for PainShieldAugust 28, 2023 | finance.yahoo.comNanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffAugust 23, 2023 | markets.businessinsider.comNanoVibronix Extends Distribution Deal With UPPI For PainShield, PainShield PlusAugust 23, 2023 | finance.yahoo.comNanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield PlusJune 14, 2023 | finance.yahoo.comNanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-GuardJune 14, 2023 | finance.yahoo.comNanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-GuardMarch 28, 2023 | finance.yahoo.comNanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)March 21, 2023 | finance.yahoo.comNanoVibronix Files Provisional U.S. Patent Application for UroShield UltraMarch 14, 2023 | finance.yahoo.comNanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord InjuryFebruary 22, 2023 | finance.yahoo.comNanoVibronix to Launch Rental Program for PainShield and UroShieldFebruary 8, 2023 | finance.yahoo.comNanoVibronix Announces Reverse Stock SplitJanuary 18, 2023 | finance.yahoo.comNanoVibronix Provides Update on Expanding Access to PainShieldDecember 31, 2022 | reuters.comNAOV.O - NanoVibronix Inc | Stock Price & Latest News | ReutersDecember 13, 2022 | finance.yahoo.comNanoVibronix Announces Partnership with Peak Medical, Ltd.December 9, 2022 | finance.yahoo.comShareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation AcceptableDecember 1, 2022 | finance.yahoo.comNanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 29, 2022 | investorplace.comWhat Is Going on With NanoVibronix (NAOV) Stock Today?November 29, 2022 | finance.yahoo.comNanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 28, 2022 | finance.yahoo.comNanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield PlusNovember 17, 2022 | finance.yahoo.comNanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021)November 16, 2022 | finance.yahoo.comNanoVibronix Announces Interim Results of Clinical Study for UroShieldNovember 16, 2022 | finance.yahoo.comInterim Results Of NanoVibronix's Uroshield Show Beneficial Effects For PatientsNovember 12, 2022 | finance.yahoo.comNanoVibronix, Inc. (NAOV) Stock Historical Prices & Data - Yahoo FinanceOctober 19, 2022 | marketscreener.comNANOVIBRONIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.comOctober 19, 2022 | seekingalpha.comNanoVibronix receives extension to satisfy Nasdaq bid price requirement - Seeking AlphaOctober 19, 2022 | businesswire.comNanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement - Business WireOctober 19, 2022 | finance.yahoo.comNanoVibronix Receives Extension to Satisfy Nasdaq Price RequirementOctober 13, 2022 | streetinsider.comForm PRE 14A NanoVibronix, Inc. For: Oct 12 - StreetInsider.com Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. NAOV Media Mentions By Week NAOV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAOV News Sentiment▼1.890.57▲Average Medical News Sentiment NAOV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAOV Articles This Week▼10▲NAOV Articles Average Week Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bone Biologics News Today Heart Test Laboratories News Today Predictive Oncology News Today Galmed Pharmaceuticals News Today Aclarion News Today Bio-Path News Today Clearmind Medicine News Today Dermata Therapeutics News Today Windtree Therapeutics News Today Salarius Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NAOV) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
